Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Endocrinology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters

Diabetes Mellitus, Type 2 Clinical Trials

A listing of Diabetes Mellitus, Type 2 medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (69) clinical trials

Do you have type 2 diabetes? A clinical research study is evaluating how an investigational medication may give you better control of your type 2 diabetes. To qualify, you must be between 18 and 80 years of age and taking metformin alone, or in combination with another oral diabetes drug ...

Phase

Dr. Paula Newton is conducting a study to determine whether a short period of exercise will lower blood sugars in teenagers and young adults with type 2 diabetes. This study includes 4 outpatient study visits over about 2 weeks. Two of the visits will take about an hour and two ...

Phase

The purpose of this study is to evaluate the cardiovascular outcomes of alogliptin compared with placebo, in addition to standard of care, in patients with type II diabetes mellitus and acute coronary syndrome. Patient Inclusion Criteria: In order to participate in this study you need to have a hgA1c level ...

Phase

Dr. Carlos Bernal-Mizrachi is conducting a study to determine whether vitamin D supplementation in diabetic African-Americans with low vitamin D levels will reduce the progression of vascular disease. This study will take about 13 months to complete. There will be about 8 outpatient study visits (about 1 – 3 hours ...

Phase

The purpose of this study is to determine if lowering blood fat levels improves heart muscle function in people with type 2 diabetes. Participation will take about 13 weeks. There will be a total of 4 outpatient visits lasting 2 – 3 hours each. There will be blood tests, questionnaires, ...

Phase

The primary efficacy objective is to determine whether treatment with dapagliflozin compared with placebo when added to current background therapy will result in a reduction in the incidence of the composite endpoint of cardiovascular death, myocardial infarction (MI), or ischemic stroke in patients with type 2 diabetes mellitus (T2DM) with ...

Phase

A study to evaluate the effect of long-term treatment with Belviq® (Lorcaserin HCI) on the incidence of major adverse cardiovascular events and conversion to Type 2 Diabetes Mellitus in obese and overweight subjects with cardiovascular disease or multiple cardiovascular risk factors. Half of the patients will be randomly assigned to ...

Phase

A randomized, open-label, parallel group real world pragmatic trial to assess the clinical and health outcomes of Toujeo® compared to commercially available basal insulins for initiation of therapy in insulin naïve patients with uncontrolled type 2 diabetes mellitus.

Phase

Comparison of TIcagrelor and Clopidogrel in Patients With Coronary Artery diseaSe and Type 2 Diabetes Mellitus (TICS-DM)

Despite the clinical benefit associated with dual therapy consisting in aspirin and clopidogrel, there are still a considerable number of patients who continue to have atherothrombotic events. Several studies have shown a wide interindividual variability in response to clopidogrel treatment and patients with poor response have an increased risk of ...

Phase